ARTICLE | Clinical News
Axaron starts stroke Phase II
August 2, 2004 7:00 AM UTC
Axaron (Heidelberg, Germany) started a German Phase II trial of AX200 to treat stroke. The company said the compound prevents the death of nerve cells and promotes regeneration of damaged brain tissue...